Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Post-Void Residual Volume or Urinary Retention Risk

MJ Drake, S MacDiarmid, S Al-Shukri, J Barkin, A Fianu-Jonasson, S Herschorn, M Huang, M Stoelzel, E Siddiqui

Research output: Contribution to journalComment/debate (Academic Journal)peer-review

2 Citations (Scopus)
380 Downloads (Pure)

Abstract

[no abstract]
Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalUrology
Volume104
Early online date16 Mar 2017
DOIs
Publication statusPublished - Jun 2017

Structured keywords

  • Centre for Surgical Research

Keywords

  • add-on therapy
  • mirabegron
  • solifenacin
  • overactive bladder
  • post-void residual volume
  • urinary retention

Fingerprint Dive into the research topics of 'Adding Mirabegron to Solifenacin to Treat Overactive Bladder Has Little Impact on Post-Void Residual Volume or Urinary Retention Risk'. Together they form a unique fingerprint.

Cite this